Csl Behring AG
CSL Behring AG, a global leader in biotherapeutics, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 1904, the company has established itself in the biotechnology industry, specialising in the development and manufacture of innovative therapies for rare and serious diseases. CSL Behring is renowned for its high-quality plasma-derived products, including immunoglobulins, clotting factors, and albumin, which are essential for treating conditions such as haemophilia and immune deficiencies. The company’s commitment to research and development has led to significant advancements in patient care, positioning it as a trusted name in the healthcare sector. With a strong market presence and a dedication to improving patient outcomes, CSL Behring AG continues to achieve notable milestones, reinforcing its reputation as a pioneer in the biopharmaceutical landscape.
DitchCarbon Score
How does Csl Behring AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Csl Behring AG's score of 49 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Csl Behring AG, headquartered in Switzerland (CH), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of CSL Limited, which cascades its climate commitments and targets down to Csl Behring AG. CSL Limited has established various climate initiatives, including Science Based Targets Initiative (SBTi) commitments, although specific reduction targets for Csl Behring AG are not detailed. The absence of documented reduction initiatives or climate pledges at the subsidiary level suggests that Csl Behring AG may rely on the overarching strategies and performance metrics set by CSL Limited. As part of its corporate family, Csl Behring AG is expected to align with the sustainability goals and emissions reduction strategies of CSL Limited, which are designed to address climate change and reduce carbon footprints across its operations. However, without specific data or targets at the subsidiary level, the precise impact and commitments of Csl Behring AG remain unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Csl Behring AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
